Aushon BioSystems has launched its next generation SignaturePLUS imaging and analysis system for multiplex protein biomarker analysis across preclinical, clinical and diagnostics applications in all therapeutic areas.

The SignaturePLUS system incorporates an advanced charge-coupled device (CCD) imager with custom optics designed specifically for quantitative chemiluminescent protein arrays, said the Billerica, Mass.-based Aushon BioSystems.